ZA856414B - Novel alpha-butyrolactams,pharmacologically active compositions thereof,process for the preparation thereof and their medical use - Google Patents
Novel alpha-butyrolactams,pharmacologically active compositions thereof,process for the preparation thereof and their medical useInfo
- Publication number
- ZA856414B ZA856414B ZA856414A ZA856414A ZA856414B ZA 856414 B ZA856414 B ZA 856414B ZA 856414 A ZA856414 A ZA 856414A ZA 856414 A ZA856414 A ZA 856414A ZA 856414 B ZA856414 B ZA 856414B
- Authority
- ZA
- South Africa
- Prior art keywords
- butyrolactams
- preparation
- pharmacologically active
- medical use
- active compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyrrole Compounds (AREA)
- Joining Of Building Structures In Genera (AREA)
- Package Frames And Binding Bands (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19843431257 DE3431257A1 (de) | 1984-08-24 | 1984-08-24 | Neue (delta)-butyrolactame, pharmakologisch aktive zusammensetzungen derselben, verfahren zu ihrer herstellung und ihre medizinische verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA856414B true ZA856414B (en) | 1986-04-30 |
Family
ID=6243847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA856414A ZA856414B (en) | 1984-08-24 | 1985-08-23 | Novel alpha-butyrolactams,pharmacologically active compositions thereof,process for the preparation thereof and their medical use |
Country Status (16)
Country | Link |
---|---|
US (1) | US4879390A (fr) |
EP (1) | EP0172514B1 (fr) |
JP (1) | JPH0660159B2 (fr) |
KR (1) | KR860001787A (fr) |
AT (1) | ATE46504T1 (fr) |
AU (1) | AU571729B2 (fr) |
CA (1) | CA1262250A (fr) |
DE (2) | DE3431257A1 (fr) |
DK (1) | DK385285A (fr) |
ES (2) | ES8609241A1 (fr) |
FI (1) | FI853228L (fr) |
GR (1) | GR852050B (fr) |
HU (1) | HU195774B (fr) |
IL (1) | IL76157A (fr) |
PT (1) | PT81005B (fr) |
ZA (1) | ZA856414B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU579029B2 (en) * | 1985-10-18 | 1988-11-10 | Bayer Aktiengesellschaft | Process for the preparation of ` -butyrolactams |
DE3616989A1 (de) * | 1986-05-21 | 1987-11-26 | Bayer Ag | Enantiomerenreine 4,5-disubstituierte (gamma)-butyrolactame, verfahren zu ihrer herstellung und ihre verwendung |
DE3927367A1 (de) * | 1989-08-19 | 1991-02-21 | Bayer Ag | Verfahren zur herstellung von dehydrocycloclausenamid und dessen derivate in der racemischen form und als optisch aktive (+) oder (-)-enantiomere |
DE3927370A1 (de) * | 1989-08-19 | 1991-02-21 | Bayer Ag | Verfahren zur herstellung von clausenamid und neoclausenamid und deren derivate |
JP4585073B2 (ja) * | 2000-02-15 | 2010-11-24 | 丸善製薬株式会社 | 抗男性ホルモン剤、養毛化粧料、前立腺肥大抑制剤、外用剤及び飲食品 |
EP1348696B1 (fr) * | 2002-03-26 | 2012-02-01 | Institute Of Materia Medica, Chinese Academy Of Medical Sciences | Utilisation de clausenamides optiquement actifs pour la préparation de compositions pharmaceutiques, compositions pharmaceutiques les contenant |
US6787564B2 (en) * | 2002-03-26 | 2004-09-07 | Institute Of Materia Medica, Chinese Academy Of Medical Sciences | Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use |
CN1295215C (zh) * | 2002-12-31 | 2007-01-17 | 中国医学科学院药物研究所 | 黄皮酰胺的光学活性衍生物、其制法和其药物组合物与用途 |
WO2016015333A1 (fr) * | 2014-08-01 | 2016-02-04 | F.Hoffmann-La Roche Ag | Dérivés de 2-oxa-5-azabicyclo[2.2.1]heptan-3-yl |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI325174A (fr) * | 1973-11-19 | 1975-05-20 | Sandoz Ag |
-
1984
- 1984-08-24 DE DE19843431257 patent/DE3431257A1/de not_active Withdrawn
-
1985
- 1985-08-12 AT AT85110087T patent/ATE46504T1/de not_active IP Right Cessation
- 1985-08-12 DE DE8585110087T patent/DE3573113D1/de not_active Expired
- 1985-08-12 EP EP85110087A patent/EP0172514B1/fr not_active Expired
- 1985-08-21 IL IL76157A patent/IL76157A/xx unknown
- 1985-08-22 PT PT81005A patent/PT81005B/pt unknown
- 1985-08-22 AU AU46571/85A patent/AU571729B2/en not_active Ceased
- 1985-08-22 CA CA000489253A patent/CA1262250A/fr not_active Expired
- 1985-08-22 FI FI853228A patent/FI853228L/fi not_active Application Discontinuation
- 1985-08-22 JP JP60183161A patent/JPH0660159B2/ja not_active Expired - Lifetime
- 1985-08-23 ES ES546381A patent/ES8609241A1/es not_active Expired
- 1985-08-23 DK DK385285A patent/DK385285A/da not_active Application Discontinuation
- 1985-08-23 ZA ZA856414A patent/ZA856414B/xx unknown
- 1985-08-23 KR KR1019850006078A patent/KR860001787A/ko not_active IP Right Cessation
- 1985-08-23 GR GR852050A patent/GR852050B/el unknown
- 1985-08-23 HU HU853219A patent/HU195774B/hu not_active IP Right Cessation
-
1986
- 1986-04-16 ES ES554061A patent/ES8704457A1/es not_active Expired
-
1988
- 1988-04-27 US US07/186,540 patent/US4879390A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES8704457A1 (es) | 1987-04-01 |
JPH0660159B2 (ja) | 1994-08-10 |
IL76157A0 (en) | 1985-12-31 |
CA1262250A (fr) | 1989-10-10 |
PT81005B (en) | 1987-06-26 |
HUT38904A (en) | 1986-07-28 |
ATE46504T1 (de) | 1989-10-15 |
JPS62181250A (ja) | 1987-08-08 |
DK385285A (da) | 1986-02-25 |
PT81005A (en) | 1985-09-01 |
HU195774B (en) | 1988-07-28 |
EP0172514A1 (fr) | 1986-02-26 |
FI853228A0 (fi) | 1985-08-22 |
DE3573113D1 (en) | 1989-10-26 |
DK385285D0 (da) | 1985-08-23 |
IL76157A (en) | 1988-08-31 |
ES554061A0 (es) | 1987-04-01 |
AU4657185A (en) | 1986-02-27 |
FI853228L (fi) | 1986-02-25 |
DE3431257A1 (de) | 1986-03-06 |
ES546381A0 (es) | 1986-07-16 |
EP0172514B1 (fr) | 1989-09-20 |
AU571729B2 (en) | 1988-04-21 |
US4879390A (en) | 1989-11-07 |
KR860001787A (ko) | 1986-03-22 |
ES8609241A1 (es) | 1986-07-16 |
GR852050B (fr) | 1985-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA34428C2 (uk) | Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки | |
TW352384B (en) | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals | |
ES8801785A1 (es) | Un procedimiento para la preparacion de nuevas azetidinonas sustituidas. | |
ES483756A1 (es) | Un procedimiento para la preparacion de 1-(p-metoxibenzoil) -2- pirrolidinona | |
EP0279149A3 (en) | Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same | |
DE3571982D1 (en) | Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds | |
ES8707724A1 (es) | Un procedimiento para preparar laudanos | |
ES8801243A1 (es) | Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas. | |
DE3573113D1 (en) | Novel delta-butyrolactams, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use | |
IL85945A0 (en) | Pharmaceutical compositions containing 2'-fluoronucleosides and derivatives thereof,certain such novel compounds and their preparation | |
JO1406B1 (en) | Chemical compounds | |
ES8107192A1 (es) | Un procedimiento para la preparacion de un compuesto sele- ccionado entre el grupo formado por una imidazolilurea | |
ES8301244A1 (es) | Procedimiento para la obtencion de derivados de sisomicina. | |
ES8500226A1 (es) | Un procedimiento de preparacion de imino-2-pirrolidinas. | |
ES8102147A1 (es) | Procedimiento para la obtencion de derivados de sisomicina | |
IL70664A0 (en) | Novel condensed pyrrole derivatives,process for their preparation and pharmaceutical compositions containing the same | |
ZA837332B (en) | Novel galenic form of sulpiride,process for its preparation and medicament comprising said novel form | |
ES8308833A1 (es) | "un metodo para la preparacion de 3-fenil-1-indanaminas". | |
UA37217C2 (uk) | Аналоги 15-дезоксиспергуаліну, спосіб їх одержання, фармацевтична композиція та проміжні сполуки | |
PT77986A (en) | Process to prepare pharmaceutical compositions including 3,4-dihydroxiphenylethyl amine derivatives | |
ES8605261A1 (es) | Un procedimiento para la preparacion de 1,4-aminoalquilamino-9-h-tioxaten-9-onas. | |
ES8704148A1 (es) | Un procedimiento para preparar derivados de antraciclina | |
EP0049842A3 (en) | Substituted enantholactam derivatives, a process for the preparation and a pharmaceutical composition useful in the treatment of hypertension comprising the same, and intermediates | |
ES8609301A1 (es) | Procedimiento para la obtencion de 3-metil-7-fluor-5-nitro- benzotiofeno | |
MY103900A (en) | 6-substituted 2'', 3''-dideoxynucleosides and pharmaceutical compositions |